Results 31 to 40 of about 21,359 (272)

Considering the esophagogastric junction as a ‘zone’ [PDF]

Digestive Endoscopy, 2017
Siewert's classification of adenocarcinoma of the esophagogastric junction (EGJ) classifies tumors anatomically for determining the appropriate surgical technique. According to this classification, a type II tumor, true carcinoma of the cardia, is defined as a cancer within 1 cm proximal to 2 cm distal of the EGJ.
Shin, Ichihara, Noriya, Uedo, Takuji, Gotoda   +2 more
openaire   +2 more sources

Morphology of the Esophageal Hiatus: Is It Different in 3 Types of Hiatus Hernias? [PDF]

, 2020
Background/aimsThe esophageal hiatus is formed by the right crus of the diaphragm in the majority of subjects. Contraction of the hiatus exerts a sphincter-like action on the lower esophageal sphincter (LES). The aim is to study the hiatal anatomy (using
Ghahremani, Gary, Horgan, Santiago, Kumar, Dushyant, Kunkel, David C, Mittal, Ravinder K, Zifan, Ali   +5 more
core   +1 more source

The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR [PDF]

, 2015
Purpose: Identification of critical genes which play pivotal roles in controlling tumor growth and survival will establish the basis for developing therapeutic targets. In this study, we focused on frequencies of EGFR, ErbB2 and MET gene amplification in
Farazmandfar, T., Janbabai, G., Naghshvar, F., Oladi, Z., Taghvaei, T.   +4 more
core   +1 more source

Collision carcinoma at the esophagogastric junction [PDF]

Gastric Cancer, 1999
Atrue collision carcinoma at the esophagogastric junction is rare. In this article, we report colliding double primary cancers of the esophagus and the stomach in a 68-year-old man and discuss this entity. Pathological analysis after total gastrectomy and partial esophagectomy showed the following findings.
Naohiro, Washizawa, Kazuo, Kobayashi, Hajime, Kase, Natsuki, Tokura, Tomohiko, Gotoh, Iwao, Iwasaki, Shiro, Tsujimoto   +6 more
openaire   +2 more sources

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

World Journal of Surgical Oncology, 2012
Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR.
Wang Wen-Ping, Wang Kang-Ning, Gao Qiang, Chen Long-Qi   +3 more
doaj   +1 more source

Expression of p53 protein in Barrett’s adenocarcinoma and adenocarcinoma of the gastric cardia and antrum [PDF]

, 2005
Background/Aim. Most studies of esophageal and gastric adenocarcinomas have shown a very high rate of p53 gene mutation and/or protein overexpression, but the influence of the tumor site upon the frequency of p53 protein expression has not been evaluated
Bjelović Miloš, Jovanović Ivan, Micev Marijan, Milosavljević Tomica, Mouzas Yoannis, Peško Predrag, Todorović Vera N., Tzardi Maria   +7 more
core   +1 more source

Esophageal and Esophagogastric Junction Cancers [PDF]

Journal of the National Comprehensive Cancer Network, 2011
Overview Upper gastrointestinal tract cancers originating in the esophagus, esophagogastric junction (EGJ), and stomach constitute a major health problem around the world. An estimated 37,640 new cases of and 25,070 deaths from upper gastrointestinal cancers occurred in the United States in 2010.1 A dramatic shift in the location of upper ...
Jaffer A, Ajani, James S, Barthel, David J, Bentrem, Thomas A, D'Amico, Prajnan, Das, Crystal S, Denlinger, Charles S, Fuchs, Hans, Gerdes, Robert E, Glasgow, James A, Hayman, Wayne L, Hofstetter, David H, Ilson, Rajesh N, Keswani, Lawrence R, Kleinberg, W Michael, Korn, A Craig, Lockhart, Mary F, Mulcahy, Mark B, Orringer, Raymond U, Osarogiagbon, James A, Posey, Aaron R, Sasson, Walter J, Scott, Stephen, Shibata, Vivian E M, Strong, Thomas K, Varghese, Graham, Warren, Mary Kay, Washington, Christopher, Willett, Cameron D, Wright   +28 more
openaire   +2 more sources

Endoscopic resection of giant gastrointestinal stromal tumor at the esophagogastric junction: a case report

BMC Gastroenterology, 2019
Background Gastrointestinal stromal tumors (GISTs) at the esophagogastric junction are rare and its treatment is complicated and challenging. Endoscopic resection has advantages with less complications compared to open and laparoscopic surgery.
Feng Xue, Wei Wang, Ning Shi, Xing-Bin Ma, Cheng-Xia Liu   +4 more
doaj   +1 more source

The efficacy of the application of the curative criteria of the 5rd edition Japanese gastric cancer treatment guidelines for early adenocarcinoma of the esophagogastric junction treated by endoscopic submucosal dissection

The Saudi Journal of Gastroenterology, 2021
Background: The curative criteria after endoscopic submucosal dissection for early gastric carcinoma were updated by the Japanese Gastric Cancer Association.
Zhihao Chen, Yong Liu, Lizhou Dou, Yueming Zhang, Shun He, Guiqi Wang   +5 more
doaj   +1 more source

The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction

World Journal of Surgical Oncology, 2008
Background Gastrointestinal stromal tumors (GIST) of the esophagogastric junction might pose a major problem to surgical resection. If locally advanced, extended or multivisceral resection with relevant procedural-specific morbidity and mortality is ...
Schwarzbach Matthias HM, Schildhaus Hans, Dimitrakopoulou-Strauss Antonia, Kaehler Georg, Ronellenfitsch Ulrich, Staiger Wilko I, Hohenberger Peter   +6 more
doaj   +1 more source